Company Performance Metrics
Helen Shaw: Founder & Managing DirectorPast Role: Boots Pharmaceuticals, Medical Director
Simon Bryson: CEO and FounderPast Role: GlaxoSmithKline, Team Member
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from
a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.
